Seoul, South Korea

Kyoung Chul Chae

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: I-Sens, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyoung Chul Chae: Innovator in Continuous Blood Glucose Measurement Technology

Introduction

Kyoung Chul Chae is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose monitoring. His innovative approach aims to enhance the accuracy of glucose measurements, which is crucial for individuals managing diabetes.

Latest Patents

Kyoung Chul Chae holds a patent for a Continuous Blood Glucose Measurement Apparatus. This device is designed to prevent the formation of an incision around the sensing area, which can lead to inaccurate blood glucose readings. By utilizing a guide needle that does not surround the sensing area, the device ensures that accurate measurements can be obtained from the early stages of operation. This innovation is vital for improving the quality of life for those who rely on precise glucose monitoring.

Career Highlights

Kyoung Chul Chae is associated with I-Sens, Inc., a company dedicated to developing advanced medical devices. His work at I-Sens has positioned him as a key player in the medical technology sector, focusing on solutions that address critical health monitoring needs.

Collaborations

Kyoung Chul Chae has collaborated with notable colleagues, including Hyun Ho Choi and Young Jea Kang. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies in the medical field.

Conclusion

Kyoung Chul Chae's contributions to continuous blood glucose measurement technology exemplify his commitment to improving healthcare solutions. His innovative patent reflects a significant advancement in medical technology, aimed at enhancing the accuracy of glucose monitoring for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…